Carey Danis & Lowe | Attorneys at Law
  • Home
  • Our Attorneys
    • About Carey Danis & Lowe
  • Featured Cases
  • Practice Areas
    • Antitrust
    • Class Actions
      • AT&T Cell Phone Bill Cramming
      • AT&T Telephone Bill Cramming
      • Credit Card Payment Protection
    • Defective & Faulty Medical Device Litigation
      • Guidant Defibrillator
      • Hip & Knee Replacement
      • Ob Tape & Slings
      • Transvaginal Mesh
    • Medical Malpractice
    • Personal Injury
      • Truck & Car Accidents
    • Pharmaceutical Litigation
      • Accutane®
      • Actos®
      • Asbestos Mesothelioma
      • Avandia®
      • Celexa®
      • Levaquin®
      • Lexapro®
      • Luvox®
      • Mirena®
      • NuvaRing®
      • Paxil®
      • Pradaxa®
      • Prozac®
      • Symbyax®
      • Topamax®
      • Wellbutrin®
      • Yaz® Yasmin®
      • Zoloft®
    • Product Liability
    • Securities Fraud
    • Unfair & Deceptive Trades
  • Firm News
    • Firm Resume
    • Press Release
    • Testimonials
  • Contact Us
    • via Email
    • via Facebook
    • via LinkedIn
    • via Twitter
    • via RSS
  • Blog
Like Carey Danis & Lowe on FacebookConnect With Carey Danis & Lowe on LinkedInFollow Carey Danis & Lowe on TwitterSubscribe to Carey Danis & Lowe via RSS

  P.  800.721.2519
 Ask a Nurse

small http://grotpaydayloans.com

Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy

In delivering their verdict on March 16, a jury in the Chicago DePuy Hip trial ruled in Johnson & Johnson and DePuy’s favor. In an article from the New York Times, the jury released a verdict stating that neither Johnson & Johnson nor DePuy engaged in a misleading marketing campaign to promote the metal-on-metal hip implant. In contrast to the Chicago DePuy Hip trial, in the first DePuy ASR Hip lawsuit to go to trial in California, the plaintiff Loren Kransky was awarded a compensatory award of $8.3 million. Continue Reading

DePuy ASR Trial Strum v. DePuy Hears Testimony from Orthopedic Surgeon Involved in DePuy ASR Hip Design

In the latest news to come out of the a DePuy ASR trial being heard in a Chicago court, an orthopedic surgeon, who assisted DePuy in developing the DePuy ASR Hip implant, provided testimony on April 2. In his testimony, Thomas P. Schmalzried claimed that DePuy’s design process was complete, yet if given the choice to use the DePuy ASR Hip implant today, Schmalzried admitted he would refuse, according to an article by Law 360. In fact, as an orthopedic surgeon, Schmalzried conceded that it has been a long Continue Reading

USA Today Editorial Decries Johnson & Johnson and DePuy for Failure to Properly Address Defective DePuy ASR Hip Implant

Submit Your Claim A recent USA Today editorial piece published on March 24 takes the position that Johnson & Johnson and DePuy mismanaged the development and marketing efforts behind their DePuy ASR Hip Replacement system. Stemming from our own investigation into the DePuy ASR Hip implant, lawyers at Carey Danis & Lowe agree that neither Johnson & Johnson nor their subsidiary, DePuy, correctly addressed any of the warning signs. According to the USA Today opinion piece, Johnson & Johnson and DePuy ignored red flags, and as a result, did Continue Reading

DePuy President Testifies in Strum v. DePuy: DePuy Defense Asserts DePuy ASR Hip Recall about Revision Rates not Defective Product

Submit Your Claim DePuy President, Andrew Ekdahl, delivered testimony during day three of Strum v. DePuy, a case being heard in a Chicago state court. The DePuy ASR Hip lawsuit involves Carol Strum, whose lawsuit against DePuy is the second of 10,750 DePuy ASR Hip lawsuit to go to trial. According to Ekdahl, DePuy initiated the DePuy ASR Hip recall due to the high rates of revision associated with the metal-on-metal hip implant. However, according to a Businessweek article about the Chicago case, the medical device manufacturer’s defense attorney, Continue Reading

FDA Sends Stryker Warning Letter about Negligent Business Practices

Submit Your Claim According to a Reuters report published on March 12, the U.S. Food and Drug Administration (FDA) has sent Stryker a warning letter about its business practices and its marketing strategy. The letter follows a visit by the FDA to a Styrker plant in November 2012. The FDA visited a Stryker plant in Portage, Michigan to conduct an inspection, and discovered that Stryker, the manufacturer of orthopedic implants, had been marketing implants without FDA approval. Furthermore, Stryker had also recalled one of their products without communicating this Continue Reading

Second DePuy ASR Hip Trial Begins in Chicago Court

Submit Your Claim On the heels of Johnson & Johnson’s loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11 in the Circuit Court of Cook County in Chicago, Illinois. The case is Strum v. DePuy, and involves the plaintiff, Carol Strum, a 54 year old nurse and Illinois resident. After receiving a DePuy ASR Hip implant, Strum claims that her implant proved defective after only three years. Strum’s case is the second DePuy ASR Hip Continue Reading

Kransky v. DePuy Jury Awards Plaintiff $8.3 Million Compensatory Award

Submit Your Claim On March 8, the jury in Kransky v. DePuy awarded the plaintiff in the case a compensatory award of $8.3 million. The compensatory damages to be paid to the plaintiff, Loren Kransky, by Johnson & Johnson cover Kransky’s pain and suffering after receiving an implant of the DePuy ASR Hip. However, the jury decided against awarding punitive damages because they believe that Johnson & Johnson and DePuy had supplied sufficient warning about the health risks involved with the use of the DePuy ASR Hip implant. Kransky Continue Reading

Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss

Submit Your Claim Published March 19, 2013 by PR Web St. Louis, Missouri (PRWEB) March 19, 2013 With defective medical device lawyers currently investigating DePuy ASR Hip Replacement system cases, Carey Danis & Lowe is optimistic about the future of DePuy ASR Hip lawsuits that go to trial. Kransky v. DePuy, a case being heard in a California Superior Court in Los Angeles, involved the plaintiff, Loren Kransky, and resulted in Kransky receiving a compensatory award of $8.3 million, according to a New York Times report on the [DePuy trial]. Though the Continue Reading

First DePuy ASR Hip Replacement Lawsuit Goes to Trial in Los Angeles Superior Court

Submit Your Claim The first in 10,000 DePuy ASR Hip Replacement lawsuits went to trial in a California Superior Court in Los Angeles County on January 25. The case is Kransky v. DePuy. The plaintiff, Loren Kransky, is a North Dakota resident who received a DePuy ASR Hip Replacement, and filed the lawsuit claiming a defective design and manufacturer negligence. According to an article recently published by the New York Times, Johnson & Johnson was aware of a serious design flaw in the DePuy ASR Hip Replacement. However, internal Continue Reading

DePuy ASR Hip Replacement Trial Scheduled to Begin on January 22, 2013 in California Superior Court

Submit Your Claim Information from a Johnson & Johnson internal study into the safety of the DePuy ASR Hip Replacement system is suggestive that the medical device manufacturer understood the serious risks associated with their hip implant. The Johnson & Johnson internal study was recently unsealed in pretrial proceedings in a DePuy ASR Hip Replacement lawsuit in California, overseen by Judge J. Stephen Czuleger. As detailed in the internal study document, the DePuy hip implant proved defective, having a significantly high failure rate with approximately 40% of patients experiencing Continue Reading

Next Page »
  • Featured Cases & Current Litigation

    • Vaginal Mesh Litigation
    • Topamax® Birth Defects
    • Lexapro® & Birth Defects
    • Pradaxa® Internal Bleeding
    • Prozac® & Birth Defects
    • Yaz® & Yasmin® Blood Clots
    • Transvaginal Mesh Injury
    • Paxil® & Birth Defects
    • NuvaRing® Blood Clots
    • Mirena® IUD Complications
    • Asbestos Mesothelioma
    • Trucking Accidents & Passenger Vehicle Collision Settlements
  • Recent Posts & News Articles

    • NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey
    • Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award
    • Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy
    • Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer
    • Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
    • Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
    • FDA Approves New Anticoagulation Reversal Agent and Boehringer Ingelheim Updates Pradaxa Label
    • Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award
Our Offices
Saint Louis, Missouri
8235 Forsyth Ste 1100
St. Louis, MO 63105
T. 314 725 7700
F. 314 721 0905
Godfrey, Illinois
5512 Godfrey Road
Godfrey, IL 62035
T. 618 463 0644
F. 314 721 0905
Belleville, Illinois
5111 W. Main Street
Belleville, IL 62226
T. 618 212 6300
F. 314 721 0905
Vero Beach, Florida
612 Beachland Blvd
Vero Beach, FL 32963
T. 314 725 7700
F. 314 721 0905
© 2013 Carey Danis & Lowe
reVisioned.by
Toll Free P. 800-721-2519
Home • Contact • About